The Business Research Company’s Point-of-Care (POC) Coagulation Testing Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, August 24, 2026 /EINPresswire.com/ — “The point-of-care coagulation testing industry is evolving steadily, reflecting growing demand for rapid and accurate blood clotting diagnostics closer to the patient. This sector is gaining traction as healthcare providers seek faster decision-making tools and more accessible testing options outside traditional labs. Let’s explore the current market size, key growth drivers, regional insights, and the trends shaping this important healthcare niche.
Market Size and Projected Growth of the Point-of-Care Coagulation Testing Market
The point-of-care coagulation testing market has experienced consistent expansion, reaching $1.25 billion in 2025. It is forecast to climb to $1.3 billion by 2026, representing a compound annual growth rate (CAGR) of 4.2%. This growth during the historical period stems largely from the rising number of cardiovascular disease cases that require anticoagulation therapy, increasing demand for quick coagulation results in surgical and intensive care environments, early adoption of optical and mechanical testing technologies, and the broadening use of coagulation monitoring in hospitals and clinics.
Download a free sample of the point-of-care (poc) coagulation testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Looking ahead, the market is expected to continue growing steadily, anticipated to reach $1.52 billion by 2030 at a CAGR of 4.1%. Factors driving this future growth include a shift toward decentralized and home-based coagulation testing methods, wider adoption of electrochemical detection technologies, higher procedure volumes in emergency and trauma care, enhanced access to retail and direct tender channels, and a strong focus on reducing turnaround times to improve therapy outcomes. Key trends forecasted include increased use of rapid bedside coagulation tests in critical care, growing preference for portable and handheld devices, expanded testing in home care and outpatient settings, and rising demand for real-time clinical decision support through near-patient diagnostics.
Understanding Point-of-Care Coagulation Testing
Point-of-care coagulation testing involves diagnostic procedures that evaluate blood clotting directly at or near the patient’s location, instead of in centralized laboratories. These tests deliver results in real time or within minutes, which is significantly faster than traditional lab tests. This rapid feedback enables healthcare professionals to make timely treatment decisions and better manage anticoagulation therapy, improving patient outcomes.
View the full point-of-care (poc) coagulation testing market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
The Rising Impact of Cardiovascular Diseases on Market Growth
One of the primary factors propelling the point-of-care coagulation testing market is the increasing prevalence of cardiovascular diseases (CVDs). These conditions affect the heart and blood vessels and include disorders such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. POC coagulation testing plays a vital role in managing CVDs by providing immediate information on a patient’s coagulation status, allowing for prompt clinical decisions and reducing bleeding risks following cardiac procedures.
For example, in October 2024, the Centers for Disease Control and Prevention reported that in 2023, cardiovascular diseases caused approximately 919,032 deaths in the United States, accounting for one in every three deaths. Notably, about one-sixth of these fatalities occurred in adults under 65 years old. These statistics highlight the significant burden of cardiovascular conditions and underscore why rising CVD incidence continues to drive demand for point-of-care coagulation testing solutions.
Regional Overview of the Point-of-Care Coagulation Testing Market
In 2025, North America held the largest share of the global point-of-care coagulation testing market. The comprehensive market analysis includes key geographic regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Each region presents unique opportunities and challenges, contributing to the global growth narrative of this evolving healthcare segment.
Expanded capabilities in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
